Letters
Untreated controls are wrong when proved treatment exists
BMJ 2006; 332 doi: https://doi.org/10.1136/bmj.332.7544.796-b (Published 30 March 2006) Cite this as: BMJ 2006;332:796- J Martin Bland, professor of health statistics (mb55@york.ac.uk)
- University of York, York YO10 5DD
EDITOR—Mudur in his news article reports that Johnson & Johnson had added that “the placebo controlled design was required to satisfy the requirements of regulatory authorities to allow their evaluation of the risk/benefit of the drug” …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.